We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Non-Invasive Saliva Test Measures Tetanus Immunity in Children within 15 Minutes

By LabMedica International staff writers
Posted on 10 Jul 2024

Tetanus is a bacterial infection that can be deadly but is preventable through vaccination. Yet, over 20 million children globally do not receive essential childhood vaccinations, and the COVID-19 pandemic caused the coverage of the diphtheria-tetanus-pertussis vaccine to drop to its lowest in 15 years, placing more individuals at risk of severe illnesses. While there has been a general decline in tetanus worldwide, the disease still results in avoidable deaths in several low-middle-income countries (LMICs). In response, experts are now developing a non-invasive saliva test that - within 15 minutes - could identify children in the Global South who lack immunity to tetanus and may have missed crucial vaccinations.

Researchers at University of Birmingham (Birmingham, UK;) are working on a low-cost lateral flow test that allows for easy, quick immunity testing without the need for blood draws, which is the current standard. After initial laboratory tests, this new method will be put to the test in Rwanda. There, researchers will evaluate its effectiveness in real-world conditions and gauge its acceptance within the local community. The test is designed for use in various settings, from outreach programs and community gatherings to clinics and hospitals, and could significantly enhance access to immunity testing in areas where it's challenging to assess protective status and gather sero-epidemiological data. Being non-invasive and saliva-based, it eliminates the complications and costs associated with blood sampling, which is particularly beneficial for children. The researchers plan to extend trials of this test to other LMICs to measure immunity levels across different populations and support vaccination monitoring and strategy development.


Image: The new test may identify children missing immunity to tetanus and other essential vaccines (Photo courtesy of 123RF)
Image: The new test may identify children missing immunity to tetanus and other essential vaccines (Photo courtesy of 123RF)

“Our test shows if a person has protection against tetanus within 15 minutes. It can help identify individuals who are not protected and need vaccination,” said Dr. Jennifer Heaney, Research Fellow, University of Birmingham. “As tetanus vaccination features in all combined immunizations alongside other serious diseases, if an individual is unprotected against tetanus, they are also likely to be missing protection against other serious vaccine-preventable diseases. The test therefore can measure tetanus immunity but could also help identify broader gaps in vaccine provision.”

Related Links:
University of Birmingham 

 


Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Serological Pipet Controller
PIPETBOY GENIUS
New
Vasculitis Diagnostic Test
AESKULISA Vasculitis-Screen
New
Hemoglobin Stool Test
CerTest FOB 50 + 200 One Step Combo Card Test

Latest Molecular Diagnostics News

Blood-Based ctDNA Test Demonstrates Acceptable Accuracy for Colorectal Cancer Detection

MCED Tests Detect Cancers in Bloodstream Three Years Prior To Diagnosis

Revolutionary Blood Test Aims to Fast-Track Lung Cancer Patients for Targeted Therapy